NKTR
Nektar Therapeutics
43.60$
-7.3%
vs. previous close
Closing price · As of: Oct 2, 2026
Statements
Balance Sheet
All figures as a percentage of total assets in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | |
| 65.3% | 69.7% | 74.9% | 64.2% | 66.9% | 71.9% | 74.0% | 71.2% | 76.8% | 83.1% | 86.0% | 95.0% | |
| 2.8% | 11.1% | 10.5% | 0.9% | 9.1% | 4.9% | 12.9% | 2.3% | 12.4% | 8.9% | 14.6% | 5.4% | |
| 53.9% | 61.5% | 68.4% | 58.2% | 62.1% | 67.0% | 69.0% | 65.7% | 71.1% | 76.3% | 84.0% | 87.6% | |
| 0.8% | 4.0% | 2.8% | 1.0% | 2.0% | 1.9% | 2.5% | 2.0% | 1.2% | 0.6% | 0.5% | 0.6% | |
| 2.9% | 2.3% | 2.0% | 2.1% | 0.5% | 0.6% | 1.0% | 1.4% | 2.7% | 4.0% | 0.0% | – | |
| 15.9% | 14.2% | 11.5% | 9.3% | 2.3% | 3.3% | 3.9% | 15.9% | 12.1% | – | – | – | |
| 17.3% | 15.2% | 13.4% | 15.0% | 3.6% | 3.9% | 5.0% | 6.8% | 10.8% | 0.0% | – | – | |
| 17.3% | 15.2% | 13.4% | 15.0% | – | 1.4% | – | – | – | – | – | – | |
| 91.8% | 98.7% | 84.5% | 82.7% | 20.1% | 28.9% | 30.0% | 39.2% | 48.4% | 67.1% | 80.0% | 68.0% | |
| 14.5% | 12.2% | 12.7% | 11.0% | 3.8% | 17.9% | 7.5% | 7.6% | 9.6% | 12.9% | 20.2% | 19.1% | |
| 1.0% | 1.9% | 1.0% | 6.3% | 2.9% | 13.4% | 0.9% | 1.6% | 2.6% | 4.8% | 6.5% | 7.3% | |
| 0.6% | 0.5% | 0.5% | 0.9% | 0.3% | 1.0% | 1.4% | 0.9% | 1.8% | 2.5% | 3.8% | 3.8% | |
| 28.3% | 48.2% | 42.8% | 48.2% | 11.5% | – | – | – | – | – | – | – | |
| 8.2% | 1.3% | 15.5% | 17.3% | 79.9% | 71.1% | 70.0% | 60.8% | 51.6% | 32.9% | 20.0% | 32.0% | |
| -404.5% | -372.0% | -355.3% | -416.2% | -66.2% | -94.3% | -150.1% | -253.6% | -450.5% | -873.6% | -1,183.5% | -1,341.0% | |
| 1.9% | 1.8% | 1.6% | 2.0% | 0.6% | 0.6% | 0.8% | 1.1% | 1.8% | 3.2% | 4.5% | 6.0% |
Data as of: October 2, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.